G-5758
カスタマーレビュー
Based on 1 Customer Validation
G-5758 is a selective and orally effective IRE1α inhibitor with an IC50 of 38 nM (detected by the XBP1s luciferase reporter cell assay). G-5758 is still well tolerated in rats at oral doses up to 500 mg/kg. G-5758 can be used in the research of multiple myeloma.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度: 98.91%
- CAS 番号: 2413455-99-7
- 分子式: C27H24F4N6O3S
- 分子量:588.58
-
保管条件:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
You May Still Need
生物活性
製品説明
G-5758 is a selective and orally effective IRE1α inhibitor with an IC50 of 38 nM (detected by the XBP1s luciferase reporter cell assay). G-5758 is still well tolerated in rats at oral doses up to 500 mg/kg. G-5758 can be used in the research of multiple myeloma[1].
体内実験
G-5758 (500 mg/kg; oral administration; twice daily; 7 days) is well tolerated in male Sprague-Dawley rats, with a Cmax of 104,000 ng/mL and an AUC of 909,000 h·ng/mL[1].
G-5758 (250 mg/kg; oral administration; twice daily; 4 days) can suppress XBP1s levels for 12 hours in the KMS-11 xenograft mouse model, and then the XBP1s levels reboundes[1].
Pharmacokinetic Analysis in Mice[1]
G-5758 (250 mg/kg; oral administration; twice daily; 4 days) can suppress XBP1s levels for 12 hours in the KMS-11 xenograft mouse model, and then the XBP1s levels reboundes[1].
Pharmacokinetic Analysis in Mice[1]
| dose (mg/kg)/route | CL (mL/min/kg) | Vss (L/kg) | t1/2 (h) | %F |
| 1 (IV)/10 (PO) | 33.9 | 1.05 | 0.55 | 149 |